Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 27, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Are researchers finding therapies to treat the types of sarcomas?

mRNA vaccine: Efforts to dethrone coronavirus at the transcriptional level

Chinese versions of the Oxford knee score OKS: Their reliability and validity

Are researchers finding therapies to treat the types of sarcomas?
  • BiotechToday
  • World

Are researchers finding therapies to treat the types of sarcomas?

bioxone October 27, 2020October 27, 2020

Camelia Bhattacharyya, Amity University Kolkata

Potent diseases occur in both sexes, few are sex-specific; leiomyosarcoma (LMS) is one of them which affects mostly the female uterus, the limbs, and the retroperitoneum and accounts for about 11% of all adult soft tissue sarcomas (STS). While there are several types of LMS, the uterine LMS is the most common type and occurs in about 6 out of 10 lakhs of women and is the result for about 2% of all malignant uterine tumours. Recent research has shown that these LMS can be grouped into 2 major subdivisions, hLMS and oLMS. 

The subgroups can be accurately identified through transcriptome analysis. The 2 different cohorts originate from different areas; hLMS is mostly carried by women and originates from the vascular smooth muscle cells and is thus both synthetic as well as contractile in character and can also be highly differentiated as identified through the genomic testing. oLMS, on the other hand, originates from fibroblasts. 

These differentiations have also resulted in bringing to light the fact that MYOCD is an hLMS-specific driver and has strong expression. This proves that the MYOCD axis is essential for the survival of the hLMS. This again throws light on the fact that MYOCD inhibitors can act against hLMS can thus be used as therapy against these specific sarcomas. 

Also read: mRNA vaccine: Efforts to dethrone coronavirus at the transcriptional level

Source: Darbo E, Pérot G, Darmusey L, Guellec SL, Leroy L, Gaston L, Desplat N, Thébault N, Merle C, Rochaix P, Valentin T, Ferron G, Chevreau C, Bui B, Stoeckle E, Vince DR, Méeus, Terrier P, Neumann SP, Colin F, Pinieux GD, Duffaud F, Coindre J-M, Blay J-Y, Chibon F. SRF-MYOCD axis is the targetable driver of a well differentiated aggressive subtype of leiomyosarcomas. bioRxiv preprint doi:http://10.1101/2020.10.23.352336

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged fibroblasts hLMS Inhibitors LMS malignant MYOCD oLMS STS transcriptome vascular smooth muscle cells

One thought on “Are researchers finding therapies to treat the types of sarcomas?”

  1. Pingback: The link between diet and Cancer - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Chinese versions of the Oxford knee score OKS: Their reliability and validity

bioxone October 27, 2020

Anup Kumar Pandey, Amity University Kolkata Assessment of knee arthritis is done by the different Chinese versions of the Oxford Knee Score. They are Malaysian, Singaporean and Hong Kong Chinese versions that differ slightly in wordings and use of Cantonese in the Hong Kong version. 194 patients from mainland China participated in the study. Each […]

OKS

Related Post

  • BiotechToday
  • World

Mesenchymal Stem Cells Used in SARS-CoV-2 Patients Show Promising Results

bioxone January 11, 2021January 11, 2021

Sumedha Guha, Techno India University A ground-breaking randomized trial at the University Of Miami Miller School Of Medicine has given us a new treatment for SARS-CoV-2 patients. In the trial that was led by Dr. Camillo Ricordi, M.D., mesenchymal stem cells of the umbilical cord were infused into the body of patients severely affected by […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Flavored E-cigarettes cause lung cell toxicity

bioxone December 19, 2020December 19, 2020

Sristi Raj Rai, Amity University Kolkata Cigarettes are getting replaced by E-cigarettes or vaping devices where most of them are flavored. The flavorings are added to the E-liquid which also consists of propylene glycol, vegetable glycerine, and nicotine usually. This liquid produces aerosol (vapor) when heated with the help of a battery. Vapors, when inhaled, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Protection against Malaria parasite using a unique histone

BioTech Today August 20, 2021August 19, 2021

Soumya Shraddhya Paul, Amity University, Noida The SAGA complex, which includes the histone acetyltransferase GCN5 and serves as a general transcription co-activator in global gene regulation, is evolutionarily conserved from yeast to humans. In a study conducted by Jun Miao along with other researchers, Plasmodium falciparum has a divergent GCN5 complex that includes two plant […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy